Janet S. Vergis
CIK 1590794 · last filed 2026-06-05
Janet S. Vergis is a corporate insider who has filed 78 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing, for XRAY, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$3.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.53M
5
78
-$3.65M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XRAY | Director | 67,324 | $10.09 | $679.3K | $0 | 31 | 2026-06-05 |
| CHDw | Director | 17,102 | — | — | -$3.65M | 30 | 2026-05-06 |
| TEVA | Director | 73,697 | $34.63 | $2.55M | $0 | 10 | 2025-06-09 |
| AMRX | Director | 18,257 | $16.20 | $295.8K | $0 | 2 | 2019-05-08 |
| Impax Laboratories, LLC (IPXL) Delisted | Director | 12,150 | — | — | $0 | 3 | 2017-05-17 |
Recent Filings
78 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | XRAY | Grant (A) | +22,822 | $0 | EDGAR |
| 2026-05-06 | CHDw | Grant (A) | +920 | $0 | EDGAR |
| 2026-02-05 | CHDw | Mixed | — | -$665.9K | EDGAR |
| 2026-01-13 | XRAY | Grant (A) | +200 | $0 | EDGAR |
| 2025-10-15 | XRAY | Grant (A) | +179 | $0 | EDGAR |
| 2025-07-15 | XRAY | Grant (A) | +139 | $0 | EDGAR |
| 2025-07-08 | CHDw | Grant (A) | +729 | $70.1K | EDGAR |
| 2025-06-09 | TEVA | Mixed | +9,632 | $0 | EDGAR |
| 2025-05-27 | XRAY | Grant (A) | +13,880 | $0 | EDGAR |
| 2025-05-06 | CHDw | Grant (A) | +860 | $0 | EDGAR |